Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2023 Earnings Call Transcript November 8, 2023
Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.73, expectations were $-0.75.
Operator: Hello, thank you for standing by. And welcome to Xenon Pharmaceuticals Incorporated Third Quarter 2023 Earnings Conference Call. I would now like to turn the call over to Sherry Aulin, our CFO. You may now begin the conference.
Sherry Aulin: Thank you. Good afternoon, everyone. Thank you...
